- Home
- SHPH vs RSLS Comparison
SHPH vs RSLS Comparison
Compare SHPH & RSLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHPH
- RSLS
- Stock Information
- Founded
- SHPH 2012
- RSLS 2002
- Country
- SHPH United States
- RSLS United States
- Employees
- SHPH N/A
- RSLS N/A
- Industry
- SHPH Biotechnology: Pharmaceutical Preparations
- RSLS Medical/Dental Instruments
- Sector
- SHPH Health Care
- RSLS Health Care
- Exchange
- SHPH Nasdaq
- RSLS Nasdaq
- Market Cap
- SHPH 3.2M
- RSLS 3.2M
- IPO Year
- SHPH 2022
- RSLS 2007
- Fundamental
- Price
- SHPH $0.84
- RSLS $4.52
- Analyst Decision
- SHPH
- RSLS Hold
- Analyst Count
- SHPH 0
- RSLS 1
- Target Price
- SHPH N/A
- RSLS N/A
- AVG Volume (30 Days)
- SHPH 115.9K
- RSLS 21.9K
- Earning Date
- SHPH 11-13-2024
- RSLS 11-14-2024
- Dividend Yield
- SHPH N/A
- RSLS N/A
- EPS Growth
- SHPH N/A
- RSLS N/A
- EPS
- SHPH N/A
- RSLS N/A
- Revenue
- SHPH N/A
- RSLS $8,183,000.00
- Revenue This Year
- SHPH N/A
- RSLS $17.47
- Revenue Next Year
- SHPH N/A
- RSLS $20.00
- P/E Ratio
- SHPH N/A
- RSLS N/A
- Revenue Growth
- SHPH N/A
- RSLS N/A
- 52 Week Low
- SHPH $0.58
- RSLS $4.09
- 52 Week High
- SHPH $4.94
- RSLS $29.00
- Technical
- Relative Strength Index (RSI)
- SHPH 49.54
- RSLS 44.77
- Support Level
- SHPH $0.83
- RSLS $4.35
- Resistance Level
- SHPH $0.92
- RSLS $5.19
- Average True Range (ATR)
- SHPH 0.08
- RSLS 0.33
- MACD
- SHPH 0.01
- RSLS 0.04
- Stochastic Oscillator
- SHPH 51.97
- RSLS 21.18
About SHPH Shuttle Pharmaceuticals Holdings Inc.
Shuttle Pharmaceuticals Holdings Inc is a clinical stage pharmaceutical company leveraging our proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments by leveraging insights into the pillars of cancer therapy: surgery, radiation therapy, chemotherapy, and immunotherapy.
About RSLS ReShape Lifesciences Inc.
Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus.